Welcome to MBT

MicroBiome Therapeutics™ (MBT) develops and markets novel therapies that help maintain health by interacting with the gastrointestinal (GI) microbiome in specific ways. We are a leader in the development of evidence-based microbiome modulators–products designed to interact with microbial populations and their environment in the GI tract to promote healthy microbiome function.

read more

About Microbiome Modulators

MBT’s microbiome modulators are based on the growing understanding that the composition of the large populations of bacteria and other microorganisms (collectively referred to as the microbiota) resident in the human GI tract can have a significant impact on health. Microbiome modulators shift the GI microbiota and their environment in specific ways intended to achieve improved health outcomes.

read more